Skip to content

Clinical trials

Phase 2 Bone Marrow Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Marrow Diseases Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20102
20111
20132
20141
20151
20191
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Terminated3
Active, not recruiting2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Center for International Blood and Marrow Transplant Research2
Groupe Francophone des Myelodysplasies2
Shandong University2
Gilead Sciences1
H. Lee Moffitt Cancer Center and Research Institute1
Hansoh BioMedical R&D Company1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Orca Biosystems, Inc.1
Scios, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Marrow Diseases16
Hematologic Diseases10
Myelodysplastic Syndromes9
Leukemia7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Myeloproliferative Disorders4
Neoplasms4
Neoplasms by Histologic Type4
Anemia3
Immune System Diseases3

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.